What is NDC 71860-103?

71860-103 is the product NDC for Dawnzera (donidalorsen), Donidalorsen sodium 80 mg/.8mL injection, solution, listed with the FDA by Ionis Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Ionis Pharmaceuticals Inc., NDC labeler code 71860. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dawnzera?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dawnzera NDC 71860-103 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71860-103Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71860-0103Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71860-103-01	7186001030171860010301	1 SYRINGE, GLASS in 1 CARTON (71860-103-01) / .8 mL in 1 SYRINGE, GLASSMarketed from Aug 21, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dawnzera
Generic name (nonproprietary): donidalorsen
Active ingredients: Donidalorsen sodium — 80 mg/.8mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: Ionis Pharmaceuticals Inc.NDC labeler code 71860
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 219407
Marketing start: Aug 21, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 71860-103_5d6f0cc9-2a98-e4f5-e063-6394a90a8351SPL ID 5d6f0cc9-2a98-e4f5-e063-6394a90a8351

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471860010301 followed by a unit qualifier and the quantity

Package 71860-0103-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 71860-103

What is NDC 71860-103?: 71860-103 is the product NDC for Dawnzera (donidalorsen), Donidalorsen sodium 80 mg/.8mL injection, solution, listed with the FDA by Ionis Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dawnzera (Donidalorsen).
What is the active ingredient?: Donidalorsen sodium.
Who is the labeler?: Ionis Pharmaceuticals Inc., NDC labeler code 71860. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dawnzera?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Dawnzera (Donidalorsen) NDC 71860-103